Overcome the challenges of PMS2 variant calling with Devyser LynchFAP – our new NGS solution
Devyser LynchFAP is the latest addition to Devyser’s expanding hereditary cancer screening...
Bring down lab handling time from days to minutes with Devyser BRCA NGS, a next-generation single-sample test that screens BRCA1 and BRCA2 for mutations associated with breast cancer.
Learn more about our newly launched product Devyser BRCA PALB2 NGS.
Detect all mutations in BRCA1 and BRCA2
45
Less than 45 minutes hands-on time
5
Total laboratory process time of five hours, from DNA to sequencing
One tube per patient sample, no sample splitting
Devyser BRCA NGS is easy to implement and highly cost-effective, making it a good match for laboratories of any size. The kit’s ready-to-use reagents and repeatable, user-friendly process suits both manual and automated workflows. The targeted sequencing approach and uniform coverage of target regions maximizes the output of relevant sequencing data in every run.
Devyser’s unique single-tube format streamlines the workflow, reduces handling time and minimizes any risk of sample mix-up or contamination. One tube per sample avoids the need for sample splitting and supports a repeatable workflow for all sample types. The proprietary multiplex PCR primer chemistry provides full and uniform coverage of BRCA1 and BRCA2, covering all exons and exon/intron junctions. The kit uses overlapping primer design to ascertain superior indel coverage and downstream CNV analysis. Devyser BRCA NGS efficiently detects both germline and somatic mutations.
Devyser BRCA NGS is an end-to-end CE-IVD solution with integrated data interpretation software for fast, accurate result analysis. It reduces laboratory processing costs by ensuring targeted sequencing with high uniformity and by maximizing sample capacity on every next-generation sequencing flow cell. Several fully validated analysis software options, including CNV analysis, are available. These can be locally deployed or cloud-based. We also support integration with other software solutions.
Instructions for use
Enter access code found in the lower right corner of the label on the kit box.
Certificates
Download a specific Batch Release Certificate (BRC) below.
Guidelines and handbooks (2)
Product information (3)
Software settings (12)
Safety data sheets (1)
Data tables (0)
Enter access code found in the lower right corner of the label on the kit box.
Download a specific Batch Release Certificate (BRC) below.
CE-IVD
Devyser BRCA NGS
Complete sequencing and SNV and CNV determination of the BRCA1, BRCA2 genes
8-A100-8
8-A100-24
8-A100-96
Pack size: 8
Pack size: 24
Pack size: 96
RUO
Devyser BRCA NGS
Complete sequencing and SNV and CNV determination of the BRCA1, BRCA2 genes
8-A102-8
8-A102-24
8-A102-96
Pack size: 8
Pack size: 24
Pack size: 96
Complete the form below and we will be in touch promptly.
Devyser LynchFAP is the latest addition to Devyser’s expanding hereditary cancer screening...
Read More
Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA...
Read More
As a lab manager, you know the importance of streamlining workflows to maximize productivity and...
Read More
Do you know a man who has participated at least once in “Movember”? Every year, thousands of men...
Read More
Fast and effective test data analysis is crucial to achieving accurate outcomes and efficient workflows.
Dedicated software in our products makes analyzing test results quick, easy and trouble-free. For users, this means a streamlined end-to-end process with unmatched reliability and transparency.
"Disclaimer: Products mentioned here are CE-IVD marked but not FDA-cleared. Availability in each country depends on local regulatory marketing authorization status. Please consult your local sales representative for details.